Found: 17
Select item for more details and to access through your institution.
Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study.
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 11, p. 1579, doi. 10.1093/cid/ciu675
- By:
- Publication type:
- Article
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
- Published in:
- Transplant Infectious Disease, 2017, v. 19, n. 3, p. n/a, doi. 10.1111/tid.12696
- By:
- Publication type:
- Article
Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 11, p. 1533, doi. 10.1007/s40262-023-01308-5
- By:
- Publication type:
- Article
Effect of Ponesimod Exposure on Total Lymphocyte Dynamics in Patients with Multiple Sclerosis.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 9, p. 1239, doi. 10.1007/s40262-021-01019-9
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment.
- Published in:
- Drugs in R&D, 2015, v. 15, n. 3, p. 261, doi. 10.1007/s40268-015-0101-0
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of Bedaquiline‐Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 10, p. 1344, doi. 10.1002/jcph.1887
- By:
- Publication type:
- Article
Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.
- Published in:
- Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 5, p. 912, doi. 10.1111/jgh.13288
- By:
- Publication type:
- Article
Population Pharmacokinetics of AL-335 and Its Two Main Metabolites (ALS-022399, ALS-022227) in Monotherapy and in Combination with Odalasvir and/or Simeprevir.
- Published in:
- AAPS Journal, 2019, v. 21, n. 1, p. 1, doi. 10.1208/s12248-018-0272-z
- By:
- Publication type:
- Article
Characterizing the Pharmacokinetic Interaction Between Simeprevir and Odalasvir in Healthy Volunteers Using a Population Modeling Approach.
- Published in:
- AAPS Journal, 2018, v. 20, n. 6, p. 1, doi. 10.1208/s12248-018-0271-0
- By:
- Publication type:
- Article
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 961, doi. 10.1111/bcp.13519
- By:
- Publication type:
- Article
Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis.
- Published in:
- Journal of the International AIDS Society, 2014, v. 17, p. n/a, doi. 10.7448/IAS.17.4.19626
- By:
- Publication type:
- Article
Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2016, v. 15, n. 4, p. 512, doi. 10.5604/16652681.1202922
- By:
- Publication type:
- Article
Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment.
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 10, p. 1147, doi. 10.1002/jcph.545
- By:
- Publication type:
- Article
Telaprevir-based therapy in patients coinfected with chronic hepatitis C virus infection and HIV: INSIGHT study.
- Published in:
- 2016
- By:
- Publication type:
- journal article